Erratum: Diminished GABAA receptor binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety (Neuropsychopharmacology (2004) 29 (347-350) DOI: 10.1038/sj.npp.1300353);Diminished GABAA Receptor-Binding Capacity and a DNa Base Substitution in a Patient with Treatment-Resistant Depression and Anxiety

Neuropsychopharmacology

Volumn 29, Issue 2, 2004, Pages 347-350

  Kosel, Markus ^a   Rudolph, Uwe ^b   Wielepp, Peter ^a   Luginbühl, Martin ^a   Schmitt, Wolfgang ^a   Fisch, Hans U ^a   Schlaepfer, Thomas E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anxiety; Depression; ECT; GABA receptors; SPECT general anesthesia

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPRAZOLAM; AMITRIPTYLINE; CLOMIPRAMINE; ETOMIDATE; IOMAZENIL; LITHIUM; PROPOFOL; RECEPTOR SUBUNIT; TRACER;

ADULT; AMINO ACID SUBSTITUTION; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; BINDING AFFINITY; BISPECTRAL INDEX; CASE REPORT; CAUCASIAN; CONTROLLED STUDY; DRUG SENSITIVITY; ELECTROCONVULSIVE THERAPY; EXON; FRONTAL LOBE; GENETIC ANALYSIS; GENETIC CODE; HAMILTON SCALE; HUMAN; ISOTOPE LABELING; MAJOR DEPRESSION; MALE; NUCLEIC ACID BASE SUBSTITUTION; ORBIT; PANIC; PRIORITY JOURNAL; RECEPTOR BINDING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL BEHAVIOR; TEMPORAL LOBE;

EID: 0842304913     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300447     Document Type: Erratum

References (12)

1. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ (1997). The interaction of the general aesthetic etomidate with the g-aminobutyric acid type A receptor is influenced by a single amino-acid. Proc Natl Acad Sci USA 94: 11031-11103.
2. Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F et al (2003). General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA A receptor b3 subunit. FASEB J 77: 250-252.
3. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL (1998). Propofol and other intravenous anesthetics have sites of action an the gamma-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 53: 530-538.
4. Mervaala E, Könönen M, Föhr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT et al (2001). SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 66: 47-58.
5. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M (2002). The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 5: 979-984.
6. Nishikawa K, Jenkins A, Paraskevakis I, Harrison NL (2002). Volatile anesthetic actions on the GABAA receptors: contrasting effects of alpha 1(S270) and beta 2(N265) point mutations. Neuropharmacology 42: 337-345.
7. Nutt DJ, Malizia AL (2001). New insights into the role of the GABA-A-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179: 390-396.
8. Olson R (2002). GABA. In: Davis K, Charney D, Coyle J, Nemeroff C (eds). Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott Williams & Wilkins: Philadelphia, PA.
9. Rosow C, Manberg PJ (2001). Bispectral index monitoring. Anesthesiol Clin N Am 19: 947-966.
10. Sanacora G, Mason GF, Krystal JH (2000). Impairment of GABAergic transmission in depression: new insights from neuroimaging studies. Crit Rev Neurobiol 14: 23-45.
11. Siegwart R, Jurd R, Rudolph U (2002). Molecular determinants for the action of general anesthetics at recombinant a2b3g2 g-aminobutyric acid A-receptors. J Neurochem 80: 140-148.
12. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al (1998). Association of a human G-protein b3 subunit variant with hypertension. Nat Genet 18: 45-48.